VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
ALLO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
ALLOAllogene Therapeutics, Inc.
$1.50$518M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksALLOQuarterly Cash Flow

Allogene Therapeutics, Inc. (ALLO) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Allogene Therapeutics, Inc. (ALLO) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

ALLO Cash Flow Statement

Quarterly statement

ALLO Cash Flow Statement

Allogene Therapeutics, Inc. (ALLO) cash flow statement — 9-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Cash from Operations-32M-12.91M-27.6M-29.69M-39.03M-52.93M-36.7M-44.12M-63.59M-55.9M-53.71M-55.53M-61.86M-66.64M-62.1M-47.66M-42.53M-68.24M-45.44M-48.88M
Operating CF Margin %-689.57%---------254086.36%122061.36%-252409.09%-281168.18%-222130%-132119.15%-97255.1%-49454.65%-111863.93%-89090.2%-99751.02%
Operating CF Growth %18.02%75.6%24.79%32.7%38.62%5.31%31.67%20.56%-2.8%16.12%13.51%-16.53%-45.44%2.34%-36.67%2.5%-3.31%-38.33%-355.5%-30.04%
Net Income-42.68M-42.61M-38.81M-41.4M-50.94M-59.73M-59.94M-66.29M-66.36M-65M-89.26M-61.31M-79.23M-99.97M-94.85M-83.15M-74.79M-79.85M-74.87M-78.19M
Depreciation & Amortization2.65M2.87M3.06M3.1M3.11M3.1M3.23M3.21M3.64M3.56M3.48M3.57M3.64M3.51M3.31M3.86M4.85M4.16M4.24M2.56M
Stock-Based Compensation12.44M8.27M8.13M8.65M8.69M12.18M12.87M13.39M13.56M11.92M15.23M15.35M16.59M18.77M021.15M0000
Deferred Taxes000000000020.17M1.6M00000000
Other Non-Cash Items-3.84M184K226K108K2.36M-176K1.86M-15.61M2.32M-1.94M75K147K1.5M3.63M18.63M2.7M22.31M27.45M25.16M23.38M
Working Capital Changes-562K18.37M-202K-145K-2.24M-8.29M5.27M21.19M-16.75M-4.44M-3.4M-14.89M-4.36M7.42M10.81M7.79M5.1M-19.99M33K3.37M
Change in Receivables00000000000000000000
Change in Inventory00000000000000000000
Change in Payables1.03M663K599K-1.07M-422K-336K34K-7.23M6.81M-118K-302K-3.97M-4.29M1.06M2.94M1.01M1.42M-505K-2.04M189K
Cash from Investing-147.56M-29.59M33.61M11.94M43.84M6.18M54.93M-75.99M74.61M22.13M67.46M-34.27M17.16M112.94M49.6M24.91M54.03M-22.38M29.25M13.01M
Capital Expenditures-150K-9K0-243K-44K-99K-257K-429K0-8K-181K-12K-288K-1.03M-1.69M-223K-1.37M-1.9M-736K-3.35M
CapEx % of Revenue3.23%--------36.36%-411.36%54.55%1309.09%3450%3600%455.1%1597.67%3118.03%1443.14%6830.61%
Acquisitions0000000000-67.64M34.26M00000000
Investments--------------------
Other Investing000000000067.64M-34.26M00000000
Cash from Financing187.87M21.12M7.86M3.24M5.07M13.99M5.74M679K108.6M1.65M155K4.29M89.52M1.73M46K1.07M24K1.81M322K2.38M
Debt Issued (Net)00000000000000000000
Equity Issued (Net)187.87M21.12M7.86M3.24M1.51M10M5.74M679K106.3M1.65M155K3.19M89.52M046K024K1.81M322K2.38M
Dividends Paid00000000000000000000
Share Repurchases00000000000000000000
Other Financing00003.56M3.99M002.3M001.09M01.73M01.07M0000
Net Change in Cash8.32M-21.38M13.87M-14.52M9.88M-32.76M23.98M-119.43M119.63M-32.12M13.91M-85.51M44.83M48.03M-12.45M-21.68M11.53M-88.8M-16.71M-33.48M
Free Cash Flow-32.15M-12.92M-27.6M-29.93M-39.07M-53.03M-36.95M-44.54M-63.59M-55.91M-53.89M-55.54M-62.15M-67.67M-63.79M-47.88M-43.91M-70.14M-46.17M-52.23M
FCF Margin %-692.8%---------254122.73%122472.73%-252463.64%-282477.27%-225580%-135719.15%-97710.2%-51052.33%-114981.97%-90533.33%-106581.63%
FCF Growth %17.73%75.63%25.32%32.81%38.55%5.15%31.42%19.8%-2.32%17.39%15.52%-16.01%-41.54%3.51%-38.15%8.32%15.68%-25.72%-68.64%9.7%
FCF per Share-0.10-0.05-0.13-0.13-0.18-0.25-0.18-0.21-0.33-0.33-0.32-0.33-0.42-0.47-0.44-0.33-0.31-0.50-0.33-0.38
FCF Conversion (FCF/Net Income)0.75x0.30x0.71x0.72x0.77x0.89x0.61x0.67x0.96x0.86x0.60x0.89x0.78x0.67x0.65x0.57x0.57x0.85x0.61x0.63x
Interest Paid00000000000000000000
Taxes Paid00000000000000000000